Oppenheimer & Co’s uniQure QURE Stock Holding History

Oppenheimer & Co’s Portfolio QURE Stock Details QURE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-18,100	Closed	-$320K	–	1641
2024 Q4	$320K	Buy	+18,100	New	+$156K	﹤0.01%	1235
2019 Q1	–	Sell	-7,249	Closed	-$209K	–	1380
2018 Q4	$209K	Sell	7,249 -426	-6%	-$11.9K	0.01%	1086
2018 Q3	$279K	Buy	+7,675	New	+$286K	0.01%	1095

Other funds holding QURE

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Oppenheimer & Co's QURE Position: Q1 2025 in Review

Oppenheimer & Co sold out of uniQure (QURE) in Q1 2025, closing a stake of 18,100 shares — an estimated $320K sold.

Oppenheimer & Co first reported a position in QURE in Q3 2018 and held it in 3 quarters. The position peaked at $320K in Q4 2024. 141 funds tracked by Wall St. Rank hold QURE as of Q1 2025.

Oppenheimer & Co reported no remaining uniQure position as of Q1 2025 after selling out during the quarter.
Oppenheimer & Co sold 18,100 uniQure shares in Q1 2025, an estimated $320K.
Oppenheimer & Co first reported a position in uniQure in Q3 2018 and held it in 3 quarters.
Oppenheimer & Co's uniQure position peaked at $320K in Q4 2024.
141 funds tracked by Wall St. Rank held uniQure as of Q1 2025.

Based on Oppenheimer & Co's 13F filing for Q1 2025, filed 23 Apr 2025.